Takeda Pharmaceutical (TAK) operating margin

Operating margin · fiscal 2026
10.3%

Takeda Pharmaceutical (TAK) had an operating margin of 10.3% in fiscal 2026 (the year ended March 31, 2026). That is 0.1 percentage points higher than the 10.2% of fiscal 2025. Figures as of 17 Nov 2026, 21:15 UTC, from Yahoo Finance.

Key facts

Operating margin, fiscal 2026
10.3%
Change on fiscal 2025
+0.1 pts
Highest on record
14.6%fiscal 2023
Lowest on record
7.3%fiscal 2024
Fiscal years on record
42023–2026

Figures as of . Statements from Yahoo Finance. Figures, not advice.

Takeda Pharmaceutical operating margin, in more detail

Across the 4 fiscal years on record (2023–2026), the highest was 14.6% in fiscal 2023 and the lowest 7.3% in fiscal 2024. The fiscal 2026 figure is higher than in 67% of the 3 earlier fiscal years on record, whose median is 10.2%.

Gross margin was 65.1% in fiscal 2026. Net margin was -3.4% in fiscal 2026.

History · 4 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Gross margin
  • Net margin

Takeda Pharmaceutical operating margin, year by year

Takeda Pharmaceutical (TAK) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedGross marginNet margin
202610.3% 0.1 pts up65.1%-3.4%
202510.2% 2.9 pts up65.5%2.4%
20247.3% 7.3 pts down66.5%3.4%
202314.6%—69.1%7.9%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

Operating margin at health care companies of similar size

Operating margin of Takeda Pharmaceutical and comparable companies
CompanyOperating marginFiscal year
Takeda Pharmaceutical TAK10.3%2026
Cencora COR1.2%2025
Boston Scientific BSX19.8%2025
Cardinal Health CAH1.2%2026
argenx ARGX25.4%2025
Edwards Lifesciences EW27.0%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TAK

Takeda Pharmaceutical, figure by figure

Takeda Pharmaceutical (TAK) overview: price, valuation and scorecardAll health care companies by market value

Takeda Pharmaceutical operating margin: questions and answers

What is Takeda Pharmaceutical's operating margin?

Takeda Pharmaceutical (TAK) had an operating margin of 10.3% in fiscal 2026 (the year ended March 31, 2026). That is 0.1 percentage points higher than the 10.2% of fiscal 2025.

Is Takeda Pharmaceutical's operating margin high or low compared with its own history?

The fiscal 2026 figure is higher than in 67% of the 3 earlier fiscal years on record, whose median is 10.2%.

What are the highest and lowest operating margin figures on record for Takeda Pharmaceutical?

Across the 4 fiscal years on record (2023–2026), the highest was 14.6% in fiscal 2023 and the lowest 7.3% in fiscal 2024.

What are Takeda Pharmaceutical's gross and net margins?

Gross margin was 65.1% in fiscal 2026. Net margin was -3.4% in fiscal 2026.

How is Takeda Pharmaceutical's operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Takeda Pharmaceutical (TAK) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/TAK/operating-margin

Underlying data: Yahoo Finance.